RecruitingACTRN12605000037606

NIVOAD Study: Non Invasive Ventilation in Obstructive Airways Diseases Study

NIVOAD Study: Non Invasive Ventilation duration in Obstructive Airways Diseases Study


Sponsor

Dr Anthony Cross

Enrollment

192 participants

Start Date

Jun 1, 2005

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria1

  • All patients presenting to participating EDs with moderate to severe exacerbations of obstructive airways disease and judged by the clinical staff as requiring NIV. Criteria for this judgement include RR >23, SaO2 <90% on room air or <93% on 15 lpm via Hudson mask or an inability to speak in sentences.

Exclusion Criteria1

  • Obtundation (to the point of being unable to cooperate or protect the airway), primary cause of respiratory failure other than asthma or COAD, untreated pneumothorax, endotracheal intubation and a decision to withhold or withdraw treatment made by the clinician in consultation with the patient or next of kin.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

CPAP vs BiPAP The duration is unknown but it is estimated to be in the order of 120 minutes

CPAP vs BiPAP The duration is unknown but it is estimated to be in the order of 120 minutes


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000037606


Related Trials